Paul Stuka insider trades: InspireMD (NSPR) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Paul reports to the SEC
Open-market buys and sales
21 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 27, 2026 | NSPR | ↑ Buy | 20,000 | $0.88 | $18K | Direct | May 29, 2026 (2d) |
| May 14, 2026 | NSPR | ↑ Buy | 15,000 | $1.16 | $17K | Direct | May 15, 2026 (1d) |
| May 11, 2026 | NSPR | ↑ Buy | 75,626 | $1.16 | $88K | Direct | May 13, 2026 (2d) |
| May 11, 2026 | NSPR | ↑ Buy | 75,626 | $1.16 | $88K | Direct | May 12, 2026 (1d) |
| May 7, 2026 | NSPR | ↑ Buy | 7,895 | $1.14 | $9K | Direct | May 8, 2026 (1d) |
| Dec 9, 2025 | NSPR | ↑ Buy | 2,710 | $1.81 | $5K | Direct | Feb 23, 2026 (76d) |
| Dec 9, 2025 | NSPR | ↑ Buy | 5,073 | $1.81 | $9K | Direct | Dec 11, 2025 (2d) |
| Dec 5, 2025 | NSPR | ↑ Buy | 5,073 | $1.86 | $9K | Direct | Dec 8, 2025 (3d) |
| Dec 4, 2025 | NSPR | ↑ Buy | 10,130 | $1.85 | $19K | Direct | Dec 5, 2025 (1d) |
| Nov 12, 2025 | NSPR | ↑ Buy | 13,431 | $1.62 | $22K | Direct | Nov 13, 2025 (1d) |
| Jul 30, 2025 | NSPR | ↑ Buy | 20,661 | $2.42 | $50K | Indirect | Aug 1, 2025 (2d) |
| May 12, 2023 | NSPR | ↑ Buy | 175,000 | $1.63 | $286K | Indirect | May 16, 2023 (4d) |
| Dec 1, 2021 | NSPR | ↑ Buy | 12,037 | $3.51 | $42K | See Note | Dec 2, 2021 (1d) |
| Nov 30, 2021 | NSPR | ↑ Buy | 21,549 | $3.55 | $76K | See Note | Nov 30, 2021 (0d) |
| Nov 26, 2021 | NSPR | ↑ Buy | 1,200 | $3.55 | $4K | See Note | Nov 29, 2021 (3d) |
| Nov 24, 2021 | NSPR | ↑ Buy | 18,328 | $3.55 | $65K | See Note | Nov 26, 2021 (2d) |
| Nov 23, 2021 | NSPR | ↑ Buy | 20,392 | $3.54 | $72K | See Note | Nov 23, 2021 (0d) |
| Dec 11, 2018 | NSPR | ↓ Sell | 65 | $0.18 | $12 | See Note | Dec 11, 2018 (0d) |
| Mar 21, 2016 | NSPR | ↑ Buy | 127,119 | $0.59 | $75K | See Note | Mar 23, 2016 (2d) |
| Jul 31, 2014 | LCDX | ↑ Buy | 1,101,230 | $0.55 | $606K | See Note | Aug 1, 2014 (1d) |
| Apr 16, 2013 | NSPR | ↑ Buy | 250,000 | $2.00 | $500K | See Note | Apr 18, 2013 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other NSPR insiders
Open-market trades in the last 12 months
About Paul Stuka's insider trades
Paul Stuka is a director at InspireMD (NSPR). Since Apr 16, 2013, Paul has reported 20 open-market purchases worth $2.1M and 1 sale worth $12 on SEC Form 4. In the last 12 months: 10 buys ($284K).
Their filings also include grants and awards (20 filings), other transactions (12 filings), option exercises (2 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NSPR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.